| 前收市價 | 84.68 |
| 開市 | 85.05 |
| 買盤 | 85.82 x 100 |
| 賣出價 | 85.99 x 100 |
| 今日波幅 | 84.93 - 86.14 |
| 52 週波幅 | 78.02 - 125.83 |
| 成交量 | |
| 平均成交量 | 734,181 |
| 市值 | 20.711B |
| Beta 值 (5 年，每月) | 0.23 |
| 市盈率 (最近 12 個月) | 168.51 |
| 每股盈利 (最近 12 個月) | 0.51 |
| 業績公佈日 | 2024年5月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 2022年6月02日 |
| 1 年預測目標價 | 114.43 |
InvestorPlace3 Nasdaq Stocks to Sell in July Before They Crash & Burn
When deciding which stocks to invest in, understanding which exchanges they are listed on can make a big difference in long-term performance and perception. For most U.S.-based investors, the two exchanges they hear about the most are the New York Stock Exchange (NYSE) and the Nasdaq. The NYSE is known for its relative stability and historically blue-chip stocks. On the other hand, the Nasdaq is a staple of high-growth and more speculative ventures like information technology, biotechnology and
ZacksPfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
Pfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal Products for Human Use's positive opinion recommending marketing authorization.
BenzingaCovid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a treatment forpatients suffering from specific type of endometrial cancer. Its pharma peer, BioNTech SE (NASDAQ: BNTX) wasn’t as lucky as also on Monday, the FDA put its experimental cancer drug study on partial clinical hold. Combining Immunotherapy And Chemotherapy Is Emerging As A New Standard In Ca
